ReviewRadiology advances2026
How to implement a radiologist led whole-body MRI screening program.
Review in Radiology advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Whole-body MRI, healthcare ethics and access equity: Where are we? Where are we going?Radiology advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Screening whole-body MRI (WB-MRI) is gaining increasing attention as a tool for early disease detection, with growing adoption driven largely by consumer demand and direct-to-consumer private platforms. While WB-MRI has demonstrated utility in high-risk populations, its use in asymptomatic individuals remains controversial due to concerns about low diagnostic yield, false positives, overdiagnosis, and the lack of survival outcome data. Despite these limitations, the popularity of WB-MRI is expected to rise given the aging population and aggressive marketing by direct-to-consumer companies, underscoring the need for thoughtful and proactive engagement by radiologists. Radiologists have an obligation to ensure that scientific rigor, ethical oversight, and multidisciplinary collaboration guide the expansion of WB-MRI. This review outlines the current evidence and evolving landscape of screening WB-MRI, describes the development and implementation of a program within an academic radiology practice, and discusses the downstream implications and cost-effectiveness of WB-MRI screening. As this technology continues to expand beyond traditional indications, radiologists must play a leading role in defining best practices and ensuring that implementation remains evidence-based, transparent, and patient-centered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.